Related Experiment Videos
Fragments of human oncoprotein MDM2 reveal variable distribution within and on cultivated human hepatoma cells
T Schlott1, J G Scharf, A Soruri
1Department of Cytopathology, Georg-August-University, Goettingen, Germany. tschlott@med.uni-goettingen.de
Abstract:
Human oncoprotein MDM2 reveals a MHC class I binding motif HMDM441 characterizing MDM2 as a potential tumor antigen. To analyze the distribution of MDM2 proteins containing this motif in liver cancer cells we produced rabbit anti-HMDM441 serum. The novel antibodies bound to an MDM2 fragment of approximately 55 kDa which lacked the N-terminal region and was present in lysate and supernatant of a human hepatoma cell line overexpressing normal 90-kDa MDM2. The 55-kDa fragment was detected in the cytoplasm and nucleoli and at the nuclear envelope of hepatoma cells, whereas normal hepatocytes were negative. Double-fluorescence labeling indicated that the MDM2 fragments and MHC class I molecules were coexpressed on the surface of the hepatoma cells. Further studies must clarify whether MDM2 fragments containing motif HMDM441 are novel targets of immunotherapy and immunochemical tumor diagnosis.
Insights
Researchers identified a specific motif (HMDM441) on the human oncoprotein MDM2, suggesting it could be a tumor antigen. This MDM2 fragment was found in liver cancer cells but not normal ones, indicating potential for immunotherapy and diagnosis.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- The human oncoprotein MDM2 is implicated in cancer development.
- Identifying novel tumor antigens is crucial for developing targeted therapies and diagnostic tools.
Purpose of the Study:
- To investigate the presence and distribution of MDM2 proteins with a specific MHC class I binding motif (HMDM441) in liver cancer cells.
- To characterize MDM2 as a potential tumor antigen for immunotherapy and immunochemical diagnosis.
Main Methods:
- Production of rabbit anti-HMDM441 serum for antibody generation.
- Analysis of MDM2 protein fragments in human hepatoma cell lines and normal hepatocytes using Western blotting and immunofluorescence.
- Double-fluorescence labeling to assess coexpression with MHC class I molecules.
Main Results:
- A novel MDM2 fragment of approximately 55 kDa, lacking the N-terminal region, was identified in hepatoma cell lysate and supernatant.
- This 55-kDa MDM2 fragment was detected in the cytoplasm, nucleoli, and nuclear envelope of hepatoma cells, but not in normal hepatocytes.
- Coexpression of MDM2 fragments and MHC class I molecules was observed on the surface of hepatoma cells.
Conclusions:
- The MDM2 protein fragment containing the HMDM441 motif is specifically expressed in liver cancer cells.
- These MDM2 fragments represent potential novel targets for immunotherapy and immunochemical tumor diagnosis.